ER, Janka-Schaub GE et al. Expression levels of TEL, AML1 and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21) positive pediatric ALL. submitted. 6 Hubner S, Cazzaniga G, Flohr T, van der Velden VH, Konrad M, Potschger U et al. High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemias.